Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05544734Phase 4Completed
Phase 4, randomised trial of hydrocodone in postoperative pain (2 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Change From Baseline in Pain Scores on Postoperative Day 2. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05544734.